OPIANT PHARMACEUTICALS, INC.·4

Sep 1, 4:04 PM ET

Ruth Matthew R. 4

4 · OPIANT PHARMACEUTICALS, INC. · Filed Sep 1, 2021

Insider Transaction Report

Form 4
Period: 2021-08-31
Ruth Matthew R.
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2021-08-31$17.34/sh+2,000$34,68017,000 total

Documents

1 file
  • 4
    wf-form4_163052652615695.xmlPrimary

    FORM 4